FCGR3A and neoplasm: They added IL15 to the BiKE and called it 161533, wherein the TriKE facilitates the formation of a synapse between the NK cell (CD16) and the tumor cell (CD33), binding to the CD16 on the NK cells to trigger ADCC and the IL15 will promote NK cell activation and expansion.